| Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy WP Sheridan, RM Fox, CG Begley, D Maher, KM McGrath, CA Juttner, ... The Lancet 339 (8794), 640-644, 1992 | 1183 | 1992 |
| Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy G Morstyn, J Keech, W Sheridan, L Campbell, M Green, D Metcalf, R Fox, ... The Lancet 331 (8587), 667-672, 1988 | 907 | 1988 |
| Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 TK Warren, J Wells, RG Panchal, KS Stuthman, NL Garza, ... Nature 508 (7496), 402-405, 2014 | 717 | 2014 |
| Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation WP Sheridan, M Wolf, J Lusk, JE Layton, L Souza, G Morstyn, A Dodds, ... The Lancet 334 (8668), 891-895, 1989 | 515 | 1989 |
| Effects of polyethylene glycol–conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer M Fanucchi, J Glaspy, J Crawford, J Garst, R Figlin, W Sheridan, ... New England Journal of Medicine 336 (6), 404-409, 1997 | 355 | 1997 |
| Filgrastim in patients with chemotherapy-induced febrile neutropenia: a double-blind, placebo-controlled trial DW Maher, GJ Lieschke, M Green, J Bishop, R Stuart-Harris, M Wolf, ... Annals of Internal medicine 121 (7), 492-501, 1994 | 315 | 1994 |
| Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor JE Layton, H Hockman, WP Sheridan, G Morstyn | 290 | 1989 |
| Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers LA Harker, LK Roskos, UM Marzec, RA Carter, JK Cherry, B Sundell, ... Blood, The Journal of the American Society of Hematology 95 (8), 2514-2522, 2000 | 275 | 2000 |
| Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy LA Harker, LK Roskos, UM Marzec, RA Carter, JK Cherry, B Sundell, ... Blood 95 (8), 2514-2522, 2000 | 275 | 2000 |
| Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. JL Nichol, MM Hokom, A Hornkohl, WP Sheridan, H Ohashi, T Kato, YS Li, ... The Journal of clinical investigation 95 (6), 2973-2978, 1995 | 224 | 1995 |
| Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. G Morstyn, L Campbell, G Lieschke, JE Layton, D Maher, M O'Connor, ... Journal of Clinical Oncology 7 (10), 1554-1562, 1989 | 223 | 1989 |
| Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy GJ Lieschke, D Maher, J Cebon, M O'Connor, M Green, W Sheridan, ... Annals of internal medicine 110 (5), 357-364, 1989 | 217 | 1989 |
| Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients JA Glaspy, EJ Shpall, CF LeMaistre, RA Briddell, DM Menchaca, ... Blood, The Journal of the American Society of Hematology 90 (8), 2939-2951, 1997 | 202 | 1997 |
| BCX4430–a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease R Taylor, P Kotian, T Warren, R Panchal, S Bavari, J Julander, S Dobo, ... Journal of infection and public health 9 (3), 220-226, 2016 | 185 | 2016 |
| Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model JG Julander, V Siddharthan, J Evans, R Taylor, K Tolbert, C Apuli, ... Antiviral research 137, 14-22, 2017 | 168 | 2017 |
| Development of GnRH antagonists for prostate cancer: new approaches to treatment T Cook, WP Sheridan The oncologist 5 (2), 162-168, 2000 | 149 | 2000 |
| Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice TR Ulich, J del Castillo, G Senaldi, O Kinstler, S Yin, S Kaufman, J Tarpley, ... | 133 | 1996 |
| Effects of endotoxemia on thrombopoiesis in men P Stohlawetz, CC Folman, AEGK von dem Borne, T Pernerstorfer, ... Thrombosis and haemostasis 81 (04), 613-617, 1999 | 117 | 1999 |
| Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema E Aygören-Pürsün, A Bygum, V Grivcheva-Panovska, M Magerl, J Graff, ... New England Journal of Medicine 379 (4), 352-362, 2018 | 116 | 2018 |
| Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial B Zuraw, WR Lumry, DT Johnston, E Aygören-Pürsün, A Banerji, ... Journal of Allergy and Clinical Immunology 148 (1), 164-172. e9, 2021 | 110 | 2021 |
